Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

Sponsor
Gynecologic Oncology Group (Other)
Overall Status
Terminated
CT.gov ID
NCT00002993
Collaborator
National Cancer Institute (NCI) (NIH)
30
54
0.6

Study Details

Study Description

Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with mitomycin, doxorubicin, and cisplatin in treating patients with recurrent or advanced cancer of the uterus.

Condition or Disease Intervention/Treatment Phase
Phase 2

Detailed Description

OBJECTIVES: I. Estimate the antitumor activity of the combination of mitomycin, doxorubicin, and cisplatin (MAP) in patients with recurrent or advanced uterine sarcomas. II. Determine the nature and degree of toxicity of MAP chemotherapy in this cohort of patients.

OUTLINE: Patients receive IV doxorubicin, mitomycin, and cisplatin over 3 hours once every 3 weeks, for a minimum of 1 course. Patients who have complete response, partial response, or stable disease will continue for at least 3 courses. If side effects are not severe, patients may remain on the study regimen at the investigator's discretion for a maximum of 6 courses. All patients are followed until death.

PROJECTED ACCRUAL: The first stage of accrual is anticipated to accrue 20 evaluable patients in approximately 12 months. If indicated, a second stage will accrue approximately 10 evaluable patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Primary Purpose:
Treatment
Official Title:
Evaluation of Mitomycin, Doxorubicin and Cisplatin in the Treatment of Recurrent or Advanced Uterine Sarcomas
Study Start Date :
Aug 1, 1997
Actual Primary Completion Date :
Jan 1, 2000

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No

    DISEASE CHARACTERISTICS: Histologically confirmed advanced, persistent, or recurrent uterine sarcoma Documented disease progression after local therapy Measurable disease consisting of abdominal, pelvic, chest, or other masses that can be defined in at least two dimensions by palpation, x-ray, computed tomography or ultrasound

    PATIENT CHARACTERISTICS: Age: No age specified Performance status: Karnofsky 50%-100% Life expectancy: Not specified Hematopoietic: WBC at least 3,000/mm3 Granulocyte count at least 1,500/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater than 1.5 times normal SGOT no greater than 3 times normal Alkaline phosphatase no greater than 3 times normal Renal: Creatinine no greater than 1.5 times normal Cardiovascular: Ejection fraction within institutional normal limits Pulmonary: Not specified Other: No active infection No concurrent second malignancy other than nonmelanoma skin cancer Must be disease free of any prior malignancy for at least 5 years and not received any treatments with chemotherapy or radiation therapy for that malignancy

    PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior chemotherapy Endocrine therapy: Not specified Radiotherapy: At least 6 weeks since radiotherapy Recovered from effects of radiotherapy Surgery: Recovered from effects of surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama Comprehensive Cancer Center Birmingham Alabama United States 35294
    2 USC/Norris Comprehensive Cancer Center Los Angeles California United States 90033-0800
    3 Jonsson Comprehensive Cancer Center, UCLA Los Angeles California United States 90095-1781
    4 Chao Family Comprehensive Cancer Center Orange California United States 92868
    5 Women's Cancer Center Palo Alto California United States 94304
    6 University of Colorado Cancer Center Denver Colorado United States 80262
    7 Vincent T. Lombardi Cancer Research Center, Georgetown University Washington District of Columbia United States 20007
    8 Walter Reed Army Medical Center Washington District of Columbia United States 20307-5000
    9 H. Lee Moffitt Cancer Center and Research Institute Tampa Florida United States 33612
    10 Emory University Hospital - Atlanta Atlanta Georgia United States 30322
    11 MBCCOP - Hawaii Honolulu Hawaii United States 96813
    12 Rush-Presbyterian-St. Luke's Medical Center Chicago Illinois United States 60612
    13 University of Chicago Cancer Research Center Chicago Illinois United States 60637
    14 Indiana University Cancer Center Indianapolis Indiana United States 46202-5265
    15 University of Iowa Hospitals and Clinics Iowa City Iowa United States 52242
    16 Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky United States 40536-0084
    17 Johns Hopkins Oncology Center Baltimore Maryland United States 21287
    18 Medicine Branch Bethesda Maryland United States 20892
    19 Radiation Oncology Branch Bethesda Maryland United States 20892
    20 University of Massachusetts Memorial Medical Center Worcester Massachusetts United States 01655
    21 CCOP - Ann Arbor Regional Ann Arbor Michigan United States 48106
    22 Barbara Ann Karmanos Cancer Institute Detroit Michigan United States 48201
    23 University of Minnesota Cancer Center Minneapolis Minnesota United States 55455
    24 University of Mississippi Medical Center Jackson Mississippi United States 39216-4505
    25 Washington University School of Medicine Saint Louis Missouri United States 63110
    26 CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada United States 89106
    27 Cooper Hospital/University Medical Center Camden New Jersey United States 08103
    28 Cancer Center of Albany Medical Center Albany New York United States 12208
    29 State University of New York Health Science Center at Brooklyn Brooklyn New York United States 11203
    30 North Shore University Hospital Manhasset New York United States 11030
    31 Memorial Sloan-Kettering Cancer Center New York New York United States 10021
    32 University of Rochester Cancer Center Rochester New York United States 14642
    33 State University of New York Health Sciences Center - Stony Brook Stony Brook New York United States 11790-9832
    34 Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina United States 27599-7295
    35 Duke Comprehensive Cancer Center Durham North Carolina United States 27710
    36 Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem North Carolina United States 27157-1082
    37 Barrett Cancer Center, The University Hospital Cincinnati Ohio United States 45219
    38 Ireland Cancer Center Cleveland Ohio United States 44106-5065
    39 Cleveland Clinic Cancer Center Cleveland Ohio United States 44195
    40 Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio United States 43210
    41 University of Oklahoma College of Medicine Oklahoma City Oklahoma United States 73190
    42 Abington Memorial Hospital Abington Pennsylvania United States 19001
    43 Milton S. Hershey Medical Center Hershey Pennsylvania United States 17033
    44 University of Pennsylvania Cancer Center Philadelphia Pennsylvania United States 19104
    45 Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania United States 19107
    46 Pennsylvania Hospital Philadelphia Pennsylvania United States 19107
    47 Fox Chase Cancer Center Philadelphia Pennsylvania United States 19111
    48 Medical University of South Carolina Charleston South Carolina United States 29425-0721
    49 CCOP - Upstate Carolina Spartanburg South Carolina United States 29303
    50 Simmons Cancer Center - Dallas Dallas Texas United States 75235-9154
    51 University of Texas - MD Anderson Cancer Center Houston Texas United States 77030
    52 Cancer Center, University of Virginia HSC Charlottesville Virginia United States 22908
    53 University of Washington Medical Center Seattle Washington United States 98195-6043
    54 Tacoma General Hospital Tacoma Washington United States 98405

    Sponsors and Collaborators

    • Gynecologic Oncology Group
    • National Cancer Institute (NCI)

    Investigators

    • Study Chair: John H. Edmonson, MD, Mayo Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00002993
    Other Study ID Numbers:
    • CDR0000065540
    • GOG-87I
    First Posted:
    Sep 3, 2004
    Last Update Posted:
    Jul 9, 2013
    Last Verified:
    May 1, 2006

    Study Results

    No Results Posted as of Jul 9, 2013